Skip to main content
Michael Albert, MD, Pathology, Amherst, NY

MichaelSAlbertMD

Pathology Amherst, NY

Anatomic Pathology, Clinical Pathology

Chairman department of pathology Catholic Health System of Buffalo

Dr. Albert is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Albert's full profile

Already have an account?

  • Office

    20 Northpointe Pkwy
    Ste 100
    Amherst, NY 14228
    Phone+1 716-250-9235

Summary

  • Dr. Michael Albert is a board certified pathologist in Orchard Park, NY. He received his medical degree from Albany Medical College in 1986 and has been in practice 31 years. He specializes in anatomic pathology and clinical pathology. He is chairman of pathology for the Catholic Health System in Buffalo N.Y.
    He is a founding member and co-owner of Xcell laboratories of western New York.

Education & Training

  • University of Rochester
    University of RochesterResidency, Pathology-Anatomic and Clinical, 1992 - 1993
  • University of Rochester
    University of RochesterResidency, Obstetrics and Gynecology, 1991 - 1992
  • University of Rochester
    University of RochesterResidency, Pathology-Anatomic and Clinical, 1988 - 1991
  • Icahn School of Medicine at Mount Sinai (Morningside)
    Icahn School of Medicine at Mount Sinai (Morningside)Internship, Transitional Year, 1986 - 1987
  • Albany Medical College
    Albany Medical CollegeClass of 1986

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1987 - 2025
  • American Board of Pathology Anatomic Pathology
  • American Board of Pathology Clinical Pathology

Publications & Presentations

PubMed

Press Mentions

  • Social Media Is Fueling Enthusiasm for New Weight Loss Drugs. Are Regulators Watching?
    Social Media Is Fueling Enthusiasm for New Weight Loss Drugs. Are Regulators Watching?April 20th, 2023